Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$881M |
| 2 |
DoorDash
DASH
|
+$403M |
| 3 |
Amgen
AMGN
|
+$403M |
| 4 |
Amazon
AMZN
|
+$282M |
| 5 |
Applied Materials
AMAT
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$592M |
| 2 |
Workday
WDAY
|
+$580M |
| 3 |
United Parcel Service
UPS
|
+$468M |
| 4 |
Apple
AAPL
|
+$438M |
| 5 |
Atlassian
TEAM
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.97% |
| 2 | Healthcare | 19.05% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VTLE
2201
DELISTED
Vital Energy
VTLE
| $319K | ﹤0.01% |
6,078
-45
| -0.7% | -$2.09K |
|
2202
Enviri
NVRI
$624M
| $319K | ﹤0.01% |
34,827
+2
| +0% | +$17 |
|
2203
Varex Imaging
VREX
$462M
| $318K | ﹤0.01% |
17,587
-445,155
| -96% | -$8.17M |
|
2204
Clearwater Paper
CLW
$349M
| $318K | ﹤0.01% |
7,275
+1
| +0% | +$37 |
|
2205
Peoples Bancorp
PEBO
$1.51B
| $317K | ﹤0.01% |
10,727
+1
| +0% | +$29 |
|
2206
Summit Therapeutics
SMMT
$10.2B
| $316K | ﹤0.01% |
76,590
+15
| +0% | +$60 |
|
2207
TFS Financial
TFSL
$5.11B
| $315K | ﹤0.01% |
25,106
+2
| +0% | +$26 |
|
|
REVG
2208
DELISTED
REV Group
REVG
| $315K | ﹤0.01% |
14,221
+6
| +0% | +$112 |
|
|
HOUS
2209
DELISTED
Anywhere Real Estate
HOUS
| $314K | ﹤0.01% |
50,760
+3
| +0% | +$20 |
|
2210
AdaptHealth
AHCO
$1.47B
| $313K | ﹤0.01% |
27,181
-421,717
| -94% | -$3.58M |
|
2211
Tarsus Pharmaceuticals
TARS
$2.55B
| $313K | ﹤0.01% |
+8,596
| New | +$253K |
|
|
OSG
2212
Octave Specialty Group
OSG
$257M
| $313K | ﹤0.01% |
20,020
+1
| +0% | +$16 |
|
2213
FIGS
FIGS
$1.76B
| $312K | ﹤0.01% |
62,796
-32,043
| -34% | -$184K |
|
2214
NB Bancorp
NBBK
$993M
| $312K | ﹤0.01% |
+22,870
| New | +$320K |
|
2215
Columbia Financial
CLBK
$1.14B
| $311K | ﹤0.01% |
18,094
-1
| -0% | -$17 |
|
2216
MasterCraft Boat Holdings
MCFT
$596M
| $310K | ﹤0.01% |
13,047
+3,762
| +41% | +$80.9K |
|
2217
Relay Therapeutics
RLAY
$4B
| $309K | ﹤0.01% |
37,342
+29
| +0.1% | +$283 |
|
2218
Nu Skin
NUS
$257M
| $308K | ﹤0.01% |
22,326
| – | – |
|
2219
Center Bancorp
CNOB
$1.65B
| $308K | ﹤0.01% |
15,794
+2
| +0% | +$42 |
|
|
INN
2220
Summit Hotel Properties
INN
$766M
| $306K | ﹤0.01% |
47,104
+8
| +0% | +$52 |
|
|
CWEN.A
2221
DELISTED
Clearway Energy Class A
CWEN.A
| $306K | ﹤0.01% |
14,215
+1
| +0% | +$22 |
|
2222
JD.com
JD
$43.5B
| $306K | ﹤0.01% |
11,168
| – | – |
|
|
PRA
2223
DELISTED
ProAssurance
PRA
| $305K | ﹤0.01% |
23,684
-3
| -0% | -$39 |
|
2224
Community Trust Bancorp
CTBI
$1.42B
| $304K | ﹤0.01% |
7,143
| – | – |
|
2225
Usana Health Sciences
USNA
$419M
| $304K | ﹤0.01% |
6,258
+1
| +0% | +$49 |
|
Similar funds
Janus Henderson Group's Q1 2024 Portfolio in Review
As of Q1 2024, Janus Henderson Group held 2,613 positions worth $183B, up 9.3% from $168B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Janus Henderson Group's Q1 2024 filing shows 67 new, 1,353 increased, 903 reduced and 85 closed positions. Its largest new stake was CG Oncology: 1,521,432 shares worth $66.8M. The largest sale was Abbott, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q1 2024 buy was CG Oncology: 1,521,432 shares worth $66.8M.
- Janus Henderson Group added most to Oracle in Q1 2024, an estimated $881M increase.
- Janus Henderson Group's biggest Q1 2024 reduction was Abbott, cutting an estimated $592M.
- Janus Henderson Group fully exited Immunogen Inc in Q1 2024, selling an estimated $327M.
- Janus Henderson Group's ten largest holdings make up 28% of its $183B portfolio in Q1 2024.
- Janus Henderson Group opened 67 new positions and closed 85 in Q1 2024.
- Janus Henderson Group's portfolio value rose 9.3% quarter-over-quarter to $183B.
Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.